Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
Titel:
Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
Auteur:
Schindler, Christoph Birkenfeld, Andreas L. Hanefeld, Markolf Schatz, Ulrike Köhler, Carsta Grüneberg, Martin Tschöpe, Diethelm Blüher, Matthias Hasslacher, Christoph Bornstein, Stefan R.